These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 22022383)
41. Liver Transplant Due to Flupirtine-Induced Acute Liver Failure. Dondorf F; Croner RS; Tautenhahn HM; Felgendreff P; Ardelt M; Settmacher U; Rauchfuss F Exp Clin Transplant; 2020 Aug; 18(4):481-484. PubMed ID: 32635884 [TBL] [Abstract][Full Text] [Related]
42. Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase™. Aagaard L; Strandell J; Melskens L; Petersen PS; Holme Hansen E Drug Saf; 2012 Dec; 35(12):1171-82. PubMed ID: 23072620 [TBL] [Abstract][Full Text] [Related]
43. Preliminary Results of a Novel Algorithmic Method Aiming to Support Initial Causality Assessment of Routine Pharmacovigilance Case Reports for Medication-Induced Liver Injury: The PV-RUCAM. Scalfaro E; Streefkerk HJ; Merz M; Meier C; Lewis D Drug Saf; 2017 Aug; 40(8):715-727. PubMed ID: 28508325 [TBL] [Abstract][Full Text] [Related]
44. Evaluation of completeness of suspected adverse drug reaction reports submitted to the mexican national pharmacovigilance centre: a cross-sectional period-prevalence study. Sánchez-Sánchez B; Altagracia-Martínez M; Kravzov-Jinich J; Moreno-Bonett C; Vázquez-Moreno E; Martínez-Núñez JM Drug Saf; 2012 Oct; 35(10):837-44. PubMed ID: 22924896 [TBL] [Abstract][Full Text] [Related]
45. Knowledge, attitudes, and perceptions of pharmacists to adverse drug reaction reporting in Iran. Vessal G; Mardani Z; Mollai M Pharm World Sci; 2009 Apr; 31(2):183-7. PubMed ID: 19116770 [TBL] [Abstract][Full Text] [Related]
46. Patterns of adverse drug reaction signals in NAFDAC pharmacovigilance activities from January to June 2015: safety of drug use in Nigeria. Awodele O; Aliu R; Ali I; Oni Y; Adeyeye CM Pharmacol Res Perspect; 2018 Oct; 6(5):e00427. PubMed ID: 30324768 [TBL] [Abstract][Full Text] [Related]
47. The quality of spontaneous adverse drug reaction reports from the pharmacovigilance centre in western China. Niu R; Xiang Y; Wu T; Zhang Z; Chen Y; Feng B Expert Opin Drug Saf; 2019 Jan; 18(1):51-58. PubMed ID: 30574811 [TBL] [Abstract][Full Text] [Related]
48. Using real-world healthcare data for pharmacovigilance signal detection - the experience of the EU-ADR project. Patadia VK; Coloma P; Schuemie MJ; Herings R; Gini R; Mazzaglia G; Picelli G; Fornari C; Pedersen L; van der Lei J; Sturkenboom M; Trifirò G; Expert Rev Clin Pharmacol; 2015 Jan; 8(1):95-102. PubMed ID: 25487079 [TBL] [Abstract][Full Text] [Related]
49. Clinical experience with flupirtine in the U.S. McMahon FG; Arndt WF; Newton JJ; Montgomery PA; Perhach JL Postgrad Med J; 1987; 63 Suppl 3():81-5. PubMed ID: 3328854 [TBL] [Abstract][Full Text] [Related]
50. Pharmacovigilance in ophthalmology in Switzerland: an analysis of the most frequently reported ocular adverse drug reactions within the last 25 years. Karrer JE; Giovannoni L; Kullak-Ublick GA; Weiler S Swiss Med Wkly; 2019 Jun; 149():w20085. PubMed ID: 31256417 [TBL] [Abstract][Full Text] [Related]
51. Factors associated with spontaneous adverse drug reaction reporting among healthcare professionals in Vietnam. Le TT; Nguyen TTH; Nguyen C; Tran NH; Tran LA; Nguyen TB; Nguyen N; Nguyen HA J Clin Pharm Ther; 2020 Feb; 45(1):122-127. PubMed ID: 31486525 [TBL] [Abstract][Full Text] [Related]
52. Causal or casual? The role of causality assessment in pharmacovigilance. Meyboom RH; Hekster YA; Egberts AC; Gribnau FW; Edwards IR Drug Saf; 1997 Dec; 17(6):374-89. PubMed ID: 9429837 [TBL] [Abstract][Full Text] [Related]
53. Spontaneously reported hepatic adverse drug events in Korea: multicenter study. Kwon H; Lee SH; Kim SE; Lee JH; Jee YK; Kang HR; Park BJ; Park JW; Hong CS J Korean Med Sci; 2012 Mar; 27(3):268-73. PubMed ID: 22379337 [TBL] [Abstract][Full Text] [Related]
54. Reporting, handling, and subjective importance of adverse drug reactions among general practitioners: an exploratory cross-sectional survey. Gahr M; Connemann B; Zeiss R; Schönfeldt-Lecuona C; Dreyhaupt J; Lazik C Expert Opin Drug Saf; 2021 Aug; 20(8):979-985. PubMed ID: 34014779 [No Abstract] [Full Text] [Related]
55. Adverse Drug Reactions Reported to a National HIV & Tuberculosis Health Care Worker Hotline in South Africa: Description and Prospective Follow-Up of Reports. Njuguna C; Stewart A; Mouton JP; Blockman M; Maartens G; Swart A; Chisholm B; Jones J; Dheda M; Igumbor EU; Cohen K Drug Saf; 2016 Feb; 39(2):159-69. PubMed ID: 26547719 [TBL] [Abstract][Full Text] [Related]
56. Consistency between causality assessments obtained with two scales and their agreement with clinical judgments in hepatotoxicity. Miljkovic MM; Dobric S; Dragojevic-Simic V Pharmacoepidemiol Drug Saf; 2011 Mar; 20(3):272-85. PubMed ID: 21351309 [TBL] [Abstract][Full Text] [Related]
57. Headache as an Adverse Reaction to the Use of Medication in the Elderly: A Pharmacovigilance Study. Monteiro C; Dias B; Vaz-Patto M Int J Environ Res Public Health; 2021 Mar; 18(5):. PubMed ID: 33799926 [TBL] [Abstract][Full Text] [Related]
58. A prospective analysis of the preventability of adverse drug reactions reported in Sweden. Lövborg H; Eriksson LR; Jönsson AK; Bradley T; Hägg S Eur J Clin Pharmacol; 2012 Aug; 68(8):1183-9. PubMed ID: 22349466 [TBL] [Abstract][Full Text] [Related]
59. [Completeness of pharmacovigilance reporting in general medicine in France.]. Humbert X; Jacquot J; Alexandre J; Sassier M; Robin N; Pageot C; Kheloufi F; Joyau C; Coquerel A; Durrieu G; Fedrizzi S Sante Publique; 2019; Vol. 31(4):561-566. PubMed ID: 31959257 [TBL] [Abstract][Full Text] [Related]
60. Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986-2001). Thiessard F; Roux E; Miremont-Salamé G; Fourrier-Réglat A; Haramburu F; Tubert-Bitter P; Bégaud B Drug Saf; 2005; 28(8):731-40. PubMed ID: 16048358 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]